Watson wants a bulls-eye with the Arrow deal - Blogging Stocks

Sign Up | Log In | What is SocialPicks?

Watson wants a bulls-eye with the Arrow deal
Jun 17, 2009 07:50 PM UTC

Blogging Stocks

Percentile Score: N/A

Tracked Blogger

Profile & Performance

Subscribe to author

Symbol	Sentiment	Start	Return	Closed
WPI	n/a

Via BloggingStocks:

Filed under: Deals

While M&A activity has been mostly lackluster, this has not been the case in the pharma industry. The major players are trying to reposition themselves for changes in regulations, as well as patent expirations of mega drugs.

So, today we got another deal: Watson Pharmaceuticals (NYSE: WPI) agreed to purchase Arrow Group for $1.75 billion. The transaction will be paid in cash and stock.

Continue reading Watson wants a bulls-eye with the Arrow deal

Watson wants a bulls-eye with the Arrow deal originally appeared on BloggingStocks on Wed, 17 Jun 2009 14:50:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

Read the rest of original post »

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.